Best in Biotech 22 Oct 2024 Eight nanotechnology companies to watch out for …becomes activated in tumor cells, it is said to work nine times better than radiotherapy alone. The candidate is undergoing a phase 3 trial for head and neck cancer in… October 22, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Nov 2023 Beyond insulin: six cutting-edge diabetes biotech companies you should know about …first patient had been enrolled in a phase 1a/b study for its drug candidate ATR-258, which is a first-in-class novel b2 adrenoceptor agonist with a unique mechanism of action for… November 21, 2023 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 22 Jul 2020 Artificial Intelligence: A Superpower in the Fight Against Covid-19 …15,000 potential candidates, including approved as well as investigational drugs. All these drug candidates had previously passed the human safety testing stage. The team can rapidly identify treatment candidates, which… July 22, 2020 - 8 minutesmins - By David Kirk Share WhatsApp Twitter Linkedin Email
News and Trends 24 Jun 2022 Stramsen Biotech to look at 11 plant-based drug candidates Houston-based biotechnology firm Stramsen Biotech Inc. has announced 11 drug candidates for clinical development. Kefas Mugittu, co-CEO, made the announcement of the plant-based medical candidates. The company said the drugs… June 24, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 3 Jul 2020 Pfizer-BioNTech Covid-19 Vaccine Shows Phase I Promise …different mRNA vaccine candidates against Covid-19 and the interim results come from the most advanced of the four. All of the candidates consist of delivering mRNA molecules into the body… July 3, 2020 - 3 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 4 Jul 2023 Exeliom Biosciences closes €24M financing for lead candidate …to progress the clinical development of Exeliom Biosciences’ lead candidate, EXL01, into two new therapeutic areas: immuno-oncology and infectious diseases. EXL01 is a once daily, potentially first-in-class, microbiome-based immunotherapy containing… July 4, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Apr 2025 Six biotech companies leading the charge in hemophilia treatment …on the market can only address one disease subtype because they work by replacing a specific clotting factor. Be Biopharma Technology: Engineered B cell medicines Lead hemophilia candidate: BE-101 Recent… April 29, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Dec 2017 Grab the Tissues: Here are the 8 Biggest European Biotech Clinical Failures of 2017 …fresh start that is 2018 are fast approaching, so let’s get this over and done with: here are 2017’s biggest clinical disappointments. CureVac’s Prostate Cancer Candidate Misses Primary Endpoint The… December 12, 2017 - 7 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 25 Aug 2020 What Does Unity’s Phase II Fail Mean for European Anti-Aging Research? …has a different cellular target to that of Unity’s lead candidate, and Velabs’ candidates are antibody drugs instead of small molecules. Senolytx is branching out into developing senomorphic drugs —… August 25, 2020 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 1 Aug 2025 Oncolytic virus therapy for cancer: what’s been going on in 2025? …it in clinical trials, licensing deals, or candidates being awarded various regulatory designations. Table of contents Calidi Biotherapeutics’ oncolytic virus CLD-201 bags FDA fast track designation For instance, California-based Calidi… August 1, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Sep 2024 Six biotech companies that could revolutionize obesity treatments …slash drug prices as more and more drugs enter the market. And so are Swiss multinational Roche’s clinical candidates including its once-daily weight loss pill that has shown promise in… September 5, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 22 Nov 2017 Galapagos Cystic Fibrosis Drug Enters Phase I, Triggering €8.5M Payout …of a number of candidates that Galapagos and AbbVie are looking at to form a triple combination therapy. This particular candidate is a corrector drug, meaning it helps to restore… November 22, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email